T Cell Recognition of Autoantigens in Human Type 1 Diabetes: Clinical Perspectives
Type 1 diabetes (T1D) is an autoimmune disease driven by the activation of lymphocytes against pancreatic β-cells. Among β-cell autoantigens, preproinsulin has been ascribed a key role in the T1D process. The successive steps that control the activation of autoreactive lymphocytes have been extensiv...
Main Authors: | Roberto Mallone, Vedran Brezar, Christian Boitard |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2011/513210 |
Similar Items
-
Antigen-Based Immune Therapeutics for Type 1 Diabetes: Magic Bullets or Ordinary Blanks?
by: Slobodan Culina, et al.
Published: (2011-01-01) -
Autoantigens and Insulin Receptor in Type 1 Diabetes
by: Nandedkar, Neha Dhananjay
Published: (2019) -
Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route
by: Johnny Ludvigsson
Published: (2020-02-01) -
Insulin as a Primary Autoantigen for Type 1A Diabetes
by: G. S. Eisenbarth, et al.
Published: (2005-01-01) -
Lymphocytes and the autoimmune response to islet autoantigens in Type 1 diabetes
by: Dromey, James Anthony
Published: (2003)